Information & Referral

If you have come to our site seeking information, guidance, or referral services for yourself or another person, you have come to the right place. Wellspring is here to provide education and support to those who need assistance confronting the disease of alcoholism and drug dependence.

Information & Referral

Treatment Referrals
Suffering from an addiction problem? We can help you find a treatment facility. You can either browse through our local Treatment Directory, allow us to make suggested referrals by using our self-administered Screening Tool, or if you prefer speaking with one of our professionals, call our confidential Referral Helpline. We are available Monday through Friday from 8 a.m. to 9 p.m. You can also contact us via email at While not intended to diagnose a substance abuse problem, each of these options will help narrow your search for a program that best meets your needs. Note that the options provided do not represent an exhaustive list of all available programs or constitute an endorsement of particular programs. However, these are programs we have worked with and have consistently received positive feedback from those who have accessed their services. If you live outside of Middlesex County New Jersey, you can get help now by calling the New Jersey Addiction Services Hotline anytime at 844-276-2777. You can also access the New Jersey Mental Health Cares Information and Referral Helpline at 1-866-202-HELP (4357).
If you live outside of New Jersey, reach out to the National Council on Alcoholism and Drug Dependence at or 212-269-7797 to find your nearest local resources.
Jason Surks Memorial Resource Center
The Jason Surks Memorial Prevention Resource Center at Wellspring serves as a clearinghouse for free information about alcohol, tobacco and other drugs. Explore our vast collection of online information and helpful links, or visit us at our East Brunswick, NJ location to access free pamphlets, posters and DVD lending library.
More than just a physical and web-based library, our Resource Center is people. If you need assistance planning an educational program, need information for a health fair, or would like to contract with our staff to provide presentations in your community, please call us at 732-254-3344 or send us an email request at

Drug Companies Race to Find Painkillers That Don’t Make People High

image A number of drug companies are trying to develop strong painkillers that don't make people high, according to The Wall Street Journal.

Such drugs would be less likely to be abused.

Companies seeking new painkillers include biotech startups, as well as large drug manufacturers such as Pfizer and Biogen.

Experts say a safer painkiller could achieve annual sales in the billions of dollars.

Some companies are testing drugs that trigger different opioid receptors in the brain than the ones triggered by traditional opioids, which can cause euphoric effects. The companies hope these different receptors will have similar painkilling properties, without triggering euphoria.

Pfizer and Biogen are studying drugs that do not involve opioid receptors. Their new drugs aim to blunt the functioning of a protein that helps nerve cells send pain signals. These drugs are much less likely to trigger euphoria, according to the companies.

A lab in Salt Lake City, PRA Health Sciences, conducts dozens of studies annually to assess whether experimental drugs are likely to be abused. The lab uses volunteers who are recreational drug users, but who are not addicted. Under a deal with the Food and Drug Administration, volunteers are protected against any law enforcement action.

The lab conducted one study of an experimental drug made by Cara Therapeutics.

The study, which included 40 drug-using volunteers, compared two doses of the drug against an older opioid painkiller called pentazocine. The volunteers said both doses of the experimental drug were less desirable, and gave them a lower "feeling high" score, than pentazocine. The drug, CR845, got the same "liking" score as a placebo, but a somewhat higher score for "feeling high." Cara plans to test the drug in a much larger clinical trial.